StreetInsider.com News Articles

Burcon Announces Fiscal 2026 Results

Wed, 24 Jun 2026 16:11:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 24, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, reported results for the fiscal year ended March 31, 2026.

"Fiscal 2026 marked Burcon's transition from technology development to commercial execution," said Kip Underwood, Chief Executive Officer of Burcon. "During the year, we commissioned our production facility, achieved first commercial production and sales across our pea, canola and fava protein platforms, secured commercial agreements and expanded our customer pipeline. We also experienced growing commercial adoption of our protein ingredients, reflected in increasing sales activity and

Burcon Announces Fiscal 2026 Results

Wed, 24 Jun 2026 16:11:00 -0400

Burcon Announces Fiscal Year 2026 Conference Call and Presentation to be Held on June 24, 2026

Fri, 19 Jun 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 19, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, will hold an investor conference call and webcast on Wednesday, June 24, 2026 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal year ended March 31, 2026. The Company's financial results will be issued in a press release prior to the call.

"We are pleased to provide shareholders with an update on our fiscal 2026 results and the progress we have made in advancing Burcon's commercialization strategy. Growing customer adoption, increasing

Burcon Announces Fiscal Year 2026 Conference Call and Presentation to be Held on June 24, 2026

Fri, 19 Jun 2026 08:00:00 -0400

"We are pleased to provide shareholders with an update on our fiscal 2026 results and the progress we have made in advancing Burcon's commercialization strategy. Growing customer adoption, increasing

Burcon Accelerates Growth & Achieves New Production Record

Tue, 16 Jun 2026 08:00:00 -0400

Advancing Burcon's commercialization journey through growing commercial traction and manufacturing scale

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based proteins, today announced continued commercial and operational momentum, highlighted by strong growth in sales compared to the previous quarter and the establishment of a new production record with its manufacturing partner, marking another milestone in Burcon's transition from technology development to commercial-scale ingredient sales.

"Approximately 50% growth in sales compared to the previous quarter, combined with record production performance, reflects the continued transition of Burcon from technology

Burcon Accelerates Growth & Achieves New Production Record

Tue, 16 Jun 2026 08:00:00 -0400

Advancing Burcon's commercialization journey through growing commercial traction and manufacturing scale

"Approximately 50% growth in sales compared to the previous quarter, combined with record production performance, reflects the continued transition of Burcon from technology

Burcon appoints Chris Bunio to board, two directors depart

Wed, 29 Apr 2026 17:23:15 -0400

Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) announced the appointment of Chris Bunio to its board of directors. The Vancouver-based plant-based protein company also reported the departure of directors Jeanne McCaherty and Richard Nazur Jr.

Bunio serves as co-founder and CEO of TheoryMesh, a Winnipeg-based company focused on agriculture and food supply chain technology. He established TheoryMesh in 2021 to develop traceability solutions using blockchain and machine learning technologies.

Prior to founding TheoryMesh, Bunio worked at Microsoft for 18 years in strategy, sales and business development roles as a senior director. His responsibilities included covering public sector industries such as government, healthcare

Burcon Announces Appointment of New Director

Wed, 29 Apr 2026 17:21:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (the "Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the appointment of Mr. Chris Bunio to the board of directors (the "Board") of Burcon.

Mr. Bunio has been active in the technology industry for nearly 30 years. Mr. Bunio is a Co-founder and the CEO of TheoryMesh, a Winnipeg, Manitoba-based company focused on agriculture and food supply chains. He operationalized TheoryMesh in 2021 to develop technology for traceability solutions leveraging blockchain and machine learning.

Burcon Announces Appointment of New Director

Wed, 29 Apr 2026 17:21:00 -0400

Burcon closes $6.9 million convertible debenture financing

Mon, 27 Apr 2026 08:04:23 -0400

Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) completed the final tranche of its non-brokered private placement of convertible debentures, raising the full targeted amount of $6.9 million.

The Vancouver-based plant-based protein company issued convertible debentures worth $2.9 million in the final tranche. An insider subscribed for approximately $1.7 million of this amount. Total insider participation across all tranches reached approximately $4.4 million in principal amount.

The company received approximately $2.35 million in cash from the final tranche after offsetting $546,678 from amounts owed to an entity related to an insider subscriber. Originally, the company had expected $2.9 million of the placement to

Burcon Closes Final Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

Mon, 27 Apr 2026 07:58:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the closing of the final tranche of its previously announced non-brokered private placement (see news releases of the Company dated January 2, 2026, January 9, 2026 and February 27, 2026) of convertible debentures (the "Convertible Debentures") for an aggregate principal amount of $6.9 million (the "Private Placement").

Under the final tranche, Burcon issued Convertible Debentures in the aggregate principal amount of $2.9 million. An insider of the Company subscribed

Burcon Closes Final Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

Mon, 27 Apr 2026 07:58:00 -0400

Under the final tranche, Burcon issued Convertible Debentures in the aggregate principal amount of $2.9 million. An insider of the Company subscribed

Burcon Achieves Record Production, Expands to More than 20 Buying Customers and Evaluates Additional Capacity Expansion

Mon, 20 Apr 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based proteins, today announced recent operational and commercial milestones demonstrating accelerating momentum in its scale-up and commercialization strategy.

Over the past several weeks, the Company achieved record production, increasing average daily output by approximately 40% as compared to the calendar Q1 average, which proves production capability needed to achieve 2026 goals. In response to growing demand, Burcon and its manufacturing partner, RE ProMan LLC, are evaluating additional capacity expansion opportunities to support future customer requirements.

Burcon has

Burcon Achieves Record Production, Expands to More than 20 Buying Customers and Evaluates Additional Capacity Expansion

Mon, 20 Apr 2026 08:00:00 -0400

Burcon has

Burcon closes second tranche of convertible debenture financing

Fri, 27 Feb 2026 16:39:08 -0400

Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) closed the second tranche of its convertible debenture private placement, raising $2.75 million in the latest funding round.

The plant-based protein company has now raised a total of $4 million through the first two tranches of the financing, with company insiders subscribing for $2.7 million in convertible debentures across both rounds. The private placement targets a total of $6.9 million when completed.

The first tranche closed on December 31, 2025, raising $1.25 million in cash. The second tranche closed on February 27, 2026, for $2.75 million in cash proceeds.

A final tranche of $2.90 million is

Burcon Closes Second Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

Fri, 27 Feb 2026 16:37:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - February 27, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the closing of the second tranche of its previously announced non-brokered private placement (see news releases of the Company dated January 2, 2026 and January 9, 2026) of convertible debentures (the "Convertible Debentures") for an aggregate principal amount of $6.9 million (the "Private Placement").

Under the second tranche, Burcon issued Convertible Debentures in the aggregate principal amount of $2.75 million. To date, insiders of the Company have subscribed for Convertible

Burcon Closes Second Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

Fri, 27 Feb 2026 16:37:00 -0400

Under the second tranche, Burcon issued Convertible Debentures in the aggregate principal amount of $2.75 million. To date, insiders of the Company have subscribed for Convertible

Burcon Announces Results of Shareholder Meeting

Fri, 20 Feb 2026 15:33:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - February 20, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (the "Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce that all meeting matters put forth to shareholders, as voted on by shareholders, and where applicable, disinterested shareholders, were duly approved at its 2026 special meeting of shareholders (the "Meeting") held on February 20, 2026.

Shareholders of the Company approved the resolutions related to the Company's private placement of convertible debentures (the "Convertible Debenture Financing") and the amendment to the expiry date of its outstanding warrants held by

Burcon Announces Results of Shareholder Meeting

Fri, 20 Feb 2026 15:33:00 -0400

Burcon Announces Fiscal 2026 Third Quarter Results

Wed, 11 Feb 2026 16:07:00 -0400

Strong Q3 Revenue Growth Driven by Expanding Commercial Traction

Vancouver, British Columbia--(Newsfile Corp. - February 11, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, reported results for the fiscal third quarter ended December 31, 2025.

"Fiscal Q3 marked an important milestone in Burcon's commercial growth," said Kip Underwood, Burcon's chief executive officer. "We ramped production, fulfilled recurring customer orders, and strengthened key customer relationships, building momentum toward broader market adoption. With strong support from our manufacturing partner and insiders, we remain focused on scaling efficiently and executing our long-term

Burcon Announces Fiscal 2026 Third Quarter Results

Wed, 11 Feb 2026 16:07:00 -0400

Strong Q3 Revenue Growth Driven by Expanding Commercial Traction

Burcon Announces Details on Special Meeting of Shareholders and Amendment to Outstanding Warrants

Wed, 04 Feb 2026 17:53:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - February 4, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, will be holding a special meeting (the "Meeting") of shareholders at 10 am Pacific Time on February 20, 2026 held virtually via live webcast at https://meetnow.global/M97FRAF.

Warrant Amendment

Burcon announces that the expiry date of certain outstanding warrants of the Company ("Warrants") is being extended to June 30, 2027. Warrants held by non-insiders will be amended effective February 19, 2026, whereas the amendment to Warrants held by insiders of the Company is subject to receipt

Burcon Announces Details on Special Meeting of Shareholders and Amendment to Outstanding Warrants

Wed, 04 Feb 2026 17:53:00 -0400

Warrant Amendment

Burcon Announces Fiscal 2026 Third Quarter Conference Call and Presentation to be Held on February 11, 2026

Wed, 28 Jan 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - January 28, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, will hold an investor conference call and webcast on Wednesday, February 11, 2026 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal 2026 third quarter ended December 31, 2025. The Company's financial results will be issued in a press release prior to the call.

"Customer demand continues to exceed our expectations as commercial orders transition into recurring revenue," said Kip Underwood, Burcon's chief executive officer. "With production now supporting multiple customers,

Burcon Announces Fiscal 2026 Third Quarter Conference Call and Presentation to be Held on February 11, 2026

Wed, 28 Jan 2026 08:00:00 -0400